Cytokinetics Inc (CYTK)
Return on assets (ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | -589,526 | -526,244 | -402,552 | -242,370 | -164,135 |
| Total assets | US$ in thousands | 1,401,670 | 824,316 | 1,014,780 | 841,319 | 533,803 |
| ROA | -42.06% | -63.84% | -39.67% | -28.81% | -30.75% |
December 31, 2024 calculation
ROA = Net income ÷ Total assets
= $-589,526K ÷ $1,401,670K
= -42.06%
The return on assets (ROA) of Cytokinetics Inc has been exhibiting a declining trend over the five-year period from 2020 to 2024. The ROA was notably negative in all years, initially reported at -30.75% in 2020, and gradually worsening to -42.06% by the end of 2024. This indicates that for each year, the company is generating a negative return in relation to its total assets.
This continuous decline in ROA suggests that Cytokinetics Inc may be facing challenges in efficiently utilizing its assets to generate profits. It is crucial for the company to assess and address the factors contributing to this negative trend to improve its financial performance and overall profitability in the future.
Peer comparison
Dec 31, 2024